Erratum: Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7 (International Journal Oncology (2013) 42, (1869-1874) DOI: 10.3892/ijo.2013.1902);Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 1869-1874

  Cheng, Shujie ^a,b   Eliaz, Isaac ^d   Lin, Junfang ^a   Sliva, Daniel ^b,c  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b METHODIST RESEARCH INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d Amitabha Medical Clinic and Healing Center   (United States)

Author keywords

MMP 7; Pachymic acid; Pancreatic cancer; Poria cocos; Triterpenes

Indexed keywords

ANTINEOPLASTIC AGENT; DEHYDROPANCHYMIC ACID; K RAS PROTEIN; MATRILYSIN; PACHYMIC ACID; POLYPORENIC ACID; PORIA COCOS EXTRACT; TRITERPENE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; EPITHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; MALE; PANCREAS CANCER; PANCREAS DUCT; PORIA COCOS; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84876544466     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2346     Document Type: Erratum

References (32)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Rhee YH, Jeong SJ, Lee HJ, et al: Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells. BMC Cancer 12: 28, 2012.
3. Lee CC, Yang HL, Way TD, et al: Inhibition of cell growth and induction of apoptosis by Antrodia camphorata in HER-2/neu-overexpressing breast cancer cells through the induction of ROS, depletion of HER-2/neu and disruption of the PI3K/Akt signaling pathway. Evid Based Complement Alternat Med 2012: 702857, 2012.
4. Kuo YC, Lai CS, Tsai CY, Nagabhushanam K, Ho CT and Pan MH: Inotilone suppresses phorbol ester-induced infamma-tion and tumor promotion in mouse skin. Mol Nutr Food Res 56: 1324-1332, 2012.
5. Torkelson CJ, Sweet E, Martzen MR, et al: Phase 1 clinical trial of Trametes versicolor in women with breast cancer. ISRN Oncol 2012: 251632, 2012.
6. Rios JL: Chemical constituents and pharmacological properties of Poria cocos. Planta Med 77: 681-691, 2011.
7. Lee SM, Lee YJ, Yoon JJ, Kang DG and Lee HS: Effect of Poria cocos on hypertonic stress-induced water channel expression and apoptosis in renal collecting duct cells. J Ethnopharmacol 141: 368-376, 2012.
8. Zhao YY, Feng YL, Du X, Xi ZH, Cheng XL and Wei F: Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J Ethnopharmacol 144: 775-778, 2012.
9. Chen X, Zhang L and Cheung PC: Immunopotentiation and anti-tumor activity of carboxymethylated-sulfated beta-(1→3)-d-glucan from Poria cocos. Int Immunopharmacol 10: 398-405, 2010.
10. Kikuchi T, Uchiyama E, Ukiya M, et al: Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos. J Nat Prod 74: 137-144, 2011.
11. Ling H, Zhou L, Jia X, Gapter LA, Agarwal R and Ng KY: Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells. Mol Carcinog 48: 498-507, 2009.
12. Ling H, Zhang Y, Ng KY and Chew EH: Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 126: 609-620, 2011.
13. Zhou L, Zhang Y, Gapter LA, Ling H, Agarwal R and Ng KY: Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos. Chem Pharm Bull 56: 1459-1462, 2008.
14. Mizushina Y, Akihisa T, Ukiya M, et al: A novel DNA topoisom-erase inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos. Cancer Sci 95: 354-360, 2004. (Pubitemid 38519477)
15. Hong R, Shen MH, Xie XH and Ruan SM: Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid. Asian Pac J Cancer Prev 13: 1877-1880, 2012.
16. Ling H, Jia X, Zhang Y, et al: Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol Carcinog 49: 271-282, 2010.
17. Jiang J, Slivova V, Harvey K, Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216, 2004. (Pubitemid 39487881)
18. Sliva D, Jedinak A, Kawasaki J, Harvey K and Slivova V: Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356, 2008. (Pubitemid 351543583)
19. Sliva D, Harvey K, Mason R, Lloyd F Jr and English D: Effect of phosphatidic acid on human breast cancer cells exposed to doxorubicin. Cancer Invest 19: 783-790, 2001. (Pubitemid 33151208)
20. Lloyd FP Jr, Slivova V, Valachovicova T and Sliva D: Aspirin inhibits highly invasive prostate cancer cells. Int J Oncol 23: 1277-1283, 2003.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
22. Gapter L, Wang Z, Glinski J and Ng KY: Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun 332: 1153-1161, 2005. (Pubitemid 40798205)
23. Bournet B, Pointreau A, Souque A, et al: Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fne needle aspiration samples. Pancreatology 12: 27-34, 2012.
24. Nagaraj NS, Washington MK and Merchant NB: Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Clin Cancer Res 17: 483-493, 2011.
25. Hlavaty J, Petznek H, Holzmuller H, et al: Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer. PLoS One 7: e40611, 2012.
26. Tascilar M, Skinner HG, Rosty C, et al: The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7: 4115-4121, 2001. (Pubitemid 34044636)
27. Singh P, Srinivasan R and Wig JD: SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas 41: 541-546, 2012.
28. Crawford HC, Scoggins CR, Washington MK, Matrisian LM and Leach SD: Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 109: 1437-1444, 2002. (Pubitemid 34596169)
29. Fukushima H, Yamamoto H, Itoh F, et al: Association of matri-lysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas. Carcinogenesis 22: 1049-1052, 2001. (Pubitemid 32633603)
30. Jones LE: Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 10: 2832-2845, 2004. (Pubitemid 38509163)
31. Fukuda A, Wang SC, Morris JP I V, et al: Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19: 441-455, 2011.
32. Ling Y, Chen M, Wang K, et al: Systematic screening and characterization of the major bioactive components of Poria cocos and their metabolites in rats by LC-ESI-MS(n). Biomed Chromatogr 26: 1109-1117, 2012.